Healthcare providers may define the term “treatment-resistant depression” differently. In the SPRAVATO clinical trials, treatment-resistant depression was diagnosed in adults who were struggling with major depressive disorder and had not responded adequately to at least two different antidepressants of adequate dose and duration in the current depressive episode.